TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX: ASND) (OTCQX: ASDRF; FRA: 2D9) ("Ascendant" or the "Company”) is pleased to announce its wholly owned subsidiary, American Pacific Honduras S.A. de C.V (“AMPAC”) closed a US$5 million sho...Read More
(All dollar amounts are in U.S. dollars unless otherwise specified) Q2 2018 Highlights Include: Net income of $4.58 million and earnings per share of $0.06Adjusted EBITDA of $7.38 million; fourth consecutive quarter of positive adjusted EBITDARecord contained metal production of 22.9 million ZnE...Read More
Low-cost entry to a significant high-grade VMS polymetallic deposit within reach of mineable scale in the Iberian Pyrite Belt along trend from the transformational Neves Corvo (Lundin) and Aguas Tenidas (Trafigura) mines and Aljustrel (private) NI 43-101 Indicated Resource of 5.8 million tonne...Read More
Provides Update on Ongoing Long-Term Optimization Plan at El Mochito Q2 2018 Production Highlights: Record contained metal production of 22.9 million ZnEq lbs, an increase of 7% over Q1 2018 and 49% over Q2 2017ZnEq grade of 6.3%, representing an increase of 3% over 6.1% ZnEq in Q1 2...Read More
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the voting results of the Company’s 2018 Annual and Special Shareholder’s Meeting (the “Meeting&#...Read More
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce results from 40 diamond drill holes (12,015 metres) as part of the 2018 exploration and definition drilling program at...Read More
TORONTO, May 28, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is pleased to announce the Company has filed a Technical Report for its El Mochito mine in Honduras entitled, “ASC 2018 Technical Repor...Read More
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2018) - Chris Buncic, CEO of Ascendant Resources Inc. talks about the company's 100 percent owned, El Mochito Mine in Honduras.If you cannot view the video above, please visit:http://www.b-tv.com/ascendant-resources-ceo-clip-90sec/ Ascendant Res...Read More
(All dollar amounts are in U.S. dollars unless otherwise specified) Q1 2018 Highlights Include: Net income of $5.29 million and earnings per share of $0.07Adjusted EBITDA of $7.95 million; third consecutive quarter of positive adjusted EBITDAFree cash flow of $5.30 million resulting in a cash ba...Read More
Record contained metal production of 21.4 million ZnEq lbs, an increase of 9% over Q4 2017 and 57% over Q1 2017ZnEq grade of 6.1%, representing an increase of 15% over 5.3% ZnEq in Q4 2017 and 9% over Q1 2017 Cash balance of US$13.1 million at March 31, 2018 vs US$8.0 million at year end 2017Qua...Read More
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) is very pleased to report the results of an updated Mineral Resource & Reserve Estimate for its El Mochito mine in Honduras prep...Read More
(All dollar amounts are in U.S. dollars (“$”) unless otherwise specified) Q4 2017 Highlights Positive Free Cash Flow of $0.75 million for Q4 2017 with $8.04 million in cash exiting 2017Adjusted EBITDA of $2.28 million for Q4 2017; six consecutive months of positive Adjusted EBIT...Read More
(All dollar amounts are in U.S. dollars (“$”) unless otherwise specified) Q4 2017 Highlights Positive Free Cash Flow of $0.75 million for Q4 2017 with $8.04 million in cash exiting 2017Adjusted EBITDA of $2.28 million for Q4 2017; six consecutive months of positive Adjusted EBIT...Read More
- Baseline demographics of TransCon Growth Hormone phase 3 heiGHt Trial presented - - Multiple ascending dose cohorts from TransCon PTH phase 1 clinical trial reinforced infusion-like profile over 24 hours - COPENHAGEN, Denmark, March 19, 2018 (GLOBE NEWSWIRE) -- Ascendis P...Read More
COPENHAGEN, Denmark, March 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and...Read More
TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) announced today that it plans to release its fourth quarter and year end 2017 results after the market close on Wednesday, March 21,...Read More
COPENHAGEN, Denmark, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,947,368 American Depositary Shares (“ADSs”), each of which represents one ord...Read More
COPENHAGEN, Denmark, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary Shares (“ADSs”), each of...Read More
COPENHAGEN, Denmark, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in an upc...Read More
TORONTO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX:ASND) (OTCQX:ASDRF) (FRA:2D9) ("Ascendant" or the "Company”) today issues a correction to the drilling results reported within the January 18, 2018 press release, with the updated informatio...Read More